Table 3. Scr, Cystatin C and eGRF levels after 2 days of treatment.

	Male	Female	Total
Scr at 2 day
group A	0	0	0
group B	3.63 (2.45, 3.89) 0.023	3.53(2.58, 4.89) 0.029	3.58 (2.41, 4.92) 0.031
Cystatin C at 2 day
group A	0	0	0
group B	2.87 (2.26, 5.82) 0.014	3.69 (2.73, 4.98) 0.000	2.92 (2.83, 5.02) 0.026
eGRF at 2 day
group A	0	0	0
group B	3.67 (2.23, 5.42) 0.003	3.14 (2.21, 4.28) 0.017	3.28 (3.24, 5.14) 0.043

Results are presented as OR (95% CI) P value.

Adjust for: smoking, previous MI, albumin, HDL-C, iodixanol dosage, ACEIs/ARBs, beta-blockers and GPIIb/IIIa inhibitors.

MI=myocardial infarction, HDL-C=High density lipoprotein; ACEIs=Angiotensin-converting enzyme inhibitors; ARBs=Angiotensin-receptor blockers; GPIIb/IIIa inhibitors=Glycoprotein IIb/IIIa inhibitors; NS=Not significant.